This will allow Dr Mora to continue her fundamental research, investigating specific proteins, which have been shown to lead to the most common mutations found in DIPG – a deadly childhood brain cancer with a 0% survival rate. It’s hoped this study will hasten the identification of new therapeutic targets for DIPG.
Help fund even more ground-breaking research